[HTML][HTML] Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation

H Xiong, D Wang, L Chen, YS Choo… - The Journal of …, 2009 - Am Soc Clin Investig
H Xiong, D Wang, L Chen, YS Choo, H Ma, C Tang, K Xia, W Jiang, Z Ronai, X Zhuang…
The Journal of clinical investigation, 2009Am Soc Clin Investig
Mutations in PARKIN, pten-induced putative kinase 1 (PINK1), and DJ-1 are individually
linked to autosomal recessive early-onset familial forms of Parkinson disease (PD). Although
mutations in these genes lead to the same disease state, the functional relationships
between them and how their respective disease-associated mutations cause PD are largely
unknown. Here, we show that Parkin, PINK1, and DJ-1 formed a complex (termed PPD
complex) to promote ubiquitination and degradation of Parkin substrates, including Parkin …
Mutations in PARKIN, pten-induced putative kinase 1 (PINK1), and DJ-1 are individually linked to autosomal recessive early-onset familial forms of Parkinson disease (PD). Although mutations in these genes lead to the same disease state, the functional relationships between them and how their respective disease-associated mutations cause PD are largely unknown. Here, we show that Parkin, PINK1, and DJ-1 formed a complex (termed PPD complex) to promote ubiquitination and degradation of Parkin substrates, including Parkin itself and Synphilin-1 in neuroblastoma cells and human brain lysates. Genetic ablation of either Pink1 or Dj-1 resulted in reduced ubiquitination of endogenous Parkin as well as decreased degradation and increased accumulation of aberrantly expressed Parkin substrates. Expression of PINK1 enhanced Parkin-mediated degradation of heat shock–induced misfolded protein. In contrast, PD-pathogenic Parkin and PINK1 mutations showed reduced ability to promote degradation of Parkin substrates. This study identified a functional ubiquitin E3 ligase complex consisting of PD-associated Parkin, PINK1, and DJ-1 to promote degradation of un-/misfolded proteins and suggests that their PD-pathogenic mutations impair E3 ligase activity of the complex, which may constitute a mechanism underlying PD pathogenesis.
The Journal of Clinical Investigation